Celebrating the Science that Unites Us
Oct. 28-29, 2025
Case Comprehensive Cancer Center (Case CCC) invites members to join us on Tuesday, Oct. 28, at Tinkham Veale University Center and Wednesday, Oct. 29, at Corporate College East for an opportunity to collaborate with fellow cancer investigators and learn about the groundbreaking research happening across our consortium.
Registration closes on Oct. 15, 2025.
Keynote Speaker
Robert L. Ferris, MD, PhD
Robert L. Ferris, MD, PhD, is the Executive Director of the University of North Carolina at Chapel Hill (UNC) Lineberger Comprehensive Cancer Center and Chief of Oncology Clinical Services for UNC Health. He is a head and neck surgical oncologist and a leading expert in cancer immunotherapy.
Ferris is a pioneering cancer immunotherapist who develops and implements immunotherapy to stimulate the body’s immune system to eliminate and suppress cancer. He studies how immune cells in the tumor microenvironment can be harnessed to combat cancer and how tumor cells evade the body’s immunologic defenses.
He has led several practice-changing, prospective randomized trials—including those that led to the approval of immunotherapy for head and neck cancer—and tested treatment deintensification for good prognosis HPV+ head and neck cancer after transoral surgery. He leads a National Cancer Institute-funded immunotherapy laboratory.
Ferris currently serves on the editorial boards of the Journal of Clinical Oncology, Clinical Cancer Research, and Cancer Immunology Research, and as section editor for the Journal for ImmunoTherapy of Cancer. He is the editor-in-chief of Oral Oncology.
Ferris has published more than 420 peer-reviewed manuscripts and book chapters and was co-chair of the National Cancer Institute Head and Neck Steering Committee for six years to facilitate prospective clinical trials. He is a member of the American Society for Clinical Investigation and the recipient of numerous research and teaching awards.
Contact
Please contact Alex Carolan at axc1469@case.edu with questions.